BridgeBio Pharma Inc (NASDAQ:BBIO)
| 26.32 Delayed Data As of 4:00pm ET |  -0.26 / -0.98%Today’s Change | 6.64 Today|||52-Week Range 36.36 | +245.41% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 1 2018 | Quarter 1 2019 | -- | -- | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | -- | -- | -- |
| Depreciation And Amortization | 26.0K | 112.0K | -- | -- | ||
| Operating Expenses | Gross Income | -26.0K | -112.0K | -- | -- | |
| General Expenses | 41.8M | 63.6M | -- | -- | ||
| Research And Development | 33.8M | 44.9M | -- | -- | ||
| Total Operating Expenses | 41.8M | 63.8M | -- | -- | ||
| Non-Operating Expenses | Operating Income | -41.8M | -63.8M | -- | -- | |
| Extraordinary Charge | 0.00 | -4.6M | -- | -- | ||
| Interest Expense On Debt | 7.0K | 1.7M | -- | -- | ||
| Other Expenses | -586.0K | -1.5M | -- | -- | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -42.4M | -69.4M | -- | -- | |
| Minority Interest | -8.3M | -8.3M | -- | -- | ||
| Preferred Dividend | -3.1M | 0.00 | -- | -- | ||
| Net Income | -34.2M | -61.2M | -- | -- | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 123.0M | 123.0M | -- | -- | |
| Shares To Calculate EPS Diluted | 123.0M | 123.0M | -- | -- | ||
| Earnings Per Share | EPS | -$0.30 | -$0.50 | -- | -- | |
| EPS Diluted | -$0.30 | -$0.50 | -- | -- | ||
